Literature DB >> 11571253

Primary prevention of sudden death with implantable defibrillator therapy in patients with cardiac disease: Can we afford to do it? (Can we afford not to?).

D V Exner1, G J Klein, E N Prystowsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11571253     DOI： 10.1161/hc3801.096395

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

1.  I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator.

Authors:  Rishi Arora; Kevin J Ferrick; Tomoaki Nakata; Robert C Kaplan; Michael Rozengarten; Farhana Latif; Kaman Ng; Vanessa Marcano; Sherman Heller; John D Fisher; Mark I Travin
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

Review 2.  Use of cardiac radionuclide imaging to identify patients at risk for arrhythmic sudden cardiac death.

Authors:  Iosif Kelesidis; Mark I Travin
Journal:  J Nucl Cardiol       Date:  2012-02       Impact factor: 5.952

3.  Racial disparity and technology diffusion: the case of cardioverter defibrillator implants, 1996-2001.

Authors:  Ava Stanley; Derek DeLia; Joel C Cantor
Journal:  J Natl Med Assoc       Date:  2007-03       Impact factor: 1.798

Review 4.  Noninvasive risk stratification after myocardial infarction: rationale, current evidence and the need for definitive trials.

Authors:  Derek Exner
Journal:  Can J Cardiol       Date:  2009-06       Impact factor: 5.223

5.  Outcomes of ventricular tachycardia ablation in patients with structural heart disease: The impact of electrical storm.

Authors:  Bashar Aldhoon; Dan Wichterle; Petr Peichl; Robert Čihák; Josef Kautzner
Journal:  PLoS One       Date:  2017-02-10       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.